PubMed Health⌕ Search

Biomedical subjects

L Campeau

Publications and source records attributed to L Campeau.

At least 19 recordsLinked to original sources
PubMed1991

Long-term angiographic follow-up after angioplasty of venous coronary bypass grafts.

From April 1981 to June 1987, 57 patients underwent venous coronary bypass graft percutaneous angioplasty and had a minimal follow-up of 18 months. The procedure was elective for 28 patients, urgent for 19, and was considered as an emergency for 10. A total of 64 grafts were dilated that had been bypassed 58 +/- 48 months previously (range 2 to 184 months); lesions were located on the aortic anastomosis in 12 grafts, on the body in 38, and on the coronary anastomosis in 14. Technical success was 95.3% (61 of 64) per lesion; clinical success was 84.4% (54 of 64) per lesion and 82.5% (47 of 57) per patient. Thrombotic complications with images of a lacunar defect occurred in 11 grafts (17.2%). Predictive factors for these complications were: age of grafts 38.5% for greater than 60 month grafts versus 2.6% for less than 60 month grafts (p less than 0.01); site of lesion, body lesion 28.9% versus anastomosis none (p less than 0.01); type of lesion, concentric and short 6% versus other 29% (p less than 0.05); and recent fibrinolysis in 66% versus 10.6% (p less than 0.05). Long-term follow-up is available in the 47 successful patients and the three limited non-Q wave myocardial infarction patients. Two patients died at 13 and 17 months. Long-term angiographic follow-up is available in 45 of 48 patients or 94%. At the end of the study, 35 of 57 (61.4%) venous bypass grafts in 32 patients (64%) were patent after one or more percutaneous transluminal angioplasties.(ABSTRACT TRUNCATED AT 250 WORDS)

Angiography↗
PubMed1991

Coronary risk factors and the postbypass patient.

Atherosclerosis frequently develops in SVGs during the first 10 years. This process appears related to coronary risk factors. Several studies have found an association between hyperlipidemia and atherosclerosis documented at pathology. Late changes attributed to atherosclerosis that were observed at angiography were also significantly related to elevated serum levels of total cholesterol and triglycerides. They also were found in association with diabetes, systemic hypertension, and smoking in some studies. Several clinical studies have documented an association of one or several coronary risk factors with postoperative clinical events, including recurrence of angina, myocardial infarction, heart failure, reoperation because of clinical deterioration, and survival. These factors have been shown to act alone or in combination. The most important is an abnormal lipid profile and diabetes. Smoking and hypertension were seldom found to be significant predictors when considered separately, but appear to play an important role in association with the others. Control of coronary risk factors, particularly hyperlipidemia and smoking, seems mandatory in order to prevent SVG atherosclerosis and progression of the disease in the native coronary arteries.

Coronary Artery Bypass↗
PubMed1989

Percutaneous radial artery approach for coronary angiography.

Percutaneous entry into the distal radial artery and selective coronarography using a French 5 sheath and preshaded catheters were attempted in 100 patients with a normal Allen test. Cannulation of the radial artery was not possible in ten patients, and selective catheterization of the coronary arteries was unsuccessful in two. Manipulation of catheters presented no problem, and arterial spasm was rarely observed, only before the use of a 23-cm-long sheath. Only two complications without symptoms were observed: arterial dissection of the brachial artery in one patient and occlusion of the radial artery in another. With experience, this approach may become as effective and possibly safer than the transbrachial entry.

Adult↗
PubMed1989

Coronary artery bypass grafting with saphenous vein.

Occlusion rate of the saphenous vein is around 12-20% during the 1st year and 2-4% annually for the next 4 or 5 years. Subsequently, this rate doubles, so that at 10 years, approximately 50% of grafts become occluded due to the occurrence of graft atherosclerosis. A similar percentage of patent grafts show atherosclerotic changes at the end of the 1st decade. Sequential vein grafts probably suffer the same fate although late follow-up is lacking. Reoperation is estimated to be 30% at 10 years, as judged by angiographic criteria. The operative risk of reoperation is at least double that of primary operation; symptomatic relief appears to be of shorter duration. Recent technical changes to better preserve medial and endothelial function and to pharmacologically inhibit platelet function may lead to longer duration of the venous conduit.

Coronary Artery Bypass↗
PubMed1989

Preoperative and operative predictive variables of late clinical events following saphenous vein coronary artery bypass graft surgery.

Prediction of late clinical events was studied in a series of 145 patients who had control angiographic studies at one year and between two and 14 years after saphenous vein coronary artery bypass graft surgery. During a mean observation interval of 7.4 years, new narrowing or occlusion occurred in grafts of 59% of the patients and progression in non-bypassed arteries was observed in 66%. One or several of the following events were observed in 56% of the patients: recurrent or worse effort angina, unstable angina, myocardial infarction and heart failure. Unstable angina during follow-up was more frequent in young patients and in those who had this clinical presentation before surgery. The incidence of myocardial infarction was likewise greater in patients who had preoperative unstable angina and in those with four to five risk factors for coronary artery disease, as well as those having a lesser number of inserted grafts. Heart failure was predicted independently by either four to five risk factors, a low left ventricular contraction score or fewer grafts placed at surgery. The number of inserted grafts correlated inversely with any one of the late clinical events.

Adult↗
PubMed1988

Late thrombosis of saphenous vein coronary bypass grafts related to risk factors.

In 72% of 143 patients undergoing a second coronary bypass grafting, mural or occlusive late thrombosis was observed histologically in 69% of 173 resected grafts. Late thrombosis was particularly prevalent in atherosclerotic grafts (80.2% vs. 40.4% in nonatherosclerotic grafts) and was always noted in 16 grafts with aneurysmal dilation. Multivariate analysis of risk factors contributing to late thrombosis indicated that graft atherosclerosis and smoking after graft surgery played important roles. Univariate analysis also showed significantly higher ratios of serum total cholesterol/HDL cholesterol and of serum LDL cholesterol/HDL cholesterol in patients whose grafts were affected by late thrombosis. To prevent late thrombosis of saphenous vein aortocoronary grafts, it appears reasonable that decreasing the ratios of total cholesterol/HDL cholesterol and of LDL cholesterol/HDL cholesterol, refraining from smoking, and controlling other risk factors for atherosclerosis should be advised.

Arteriosclerosis↗
PubMed1987

Late changes in saphenous vein coronary artery bypass grafts and their implications in clinical practice.

Late changes are frequent in saphenous vein grafts. About 10 to 12 years after bypass, about one-third are occluded, one-third have wall irregularities and narrowings attributed to atherosclerosis and one-third are seemingly intact. These changes are associated with recurrence of angina and other deleterious clinical events such as unstable angina, acute myocardial infarction, heart failure and death. Intimal fibrous hyperplasia may be a precursor of these changes, which could be minimized by appropriate surgical technologies and perhaps antiplatelet therapy. These late changes appear related to serum hyperlipidemia and smoking. Optimal control of these risk factors may retard their development and subsequent clinical deterioration. Although internal mammary artery (IMA) graft is the conduit of choice because of its apparent immunity to premature atherosclerosis, and hence its longer durability, saphenous vein grafts are still placed in many old patients and others, when a short operation time is a priority, and above all in combination with IMA grafts in order to obtain complete revascularization.

Adult↗
PubMed1986

Atherosclerosis after coronary artery bypass surgery: results of recent studies and recommendations regarding prevention.

Atherosclerosis is the most frequent cause of occlusion of aortocoronary saphenous vein grafts between 5 and 10 years after coronary artery bypass surgery. The typical atherosclerotic plaque appears between 1 and 3 years after operation and, at a mean of 5 years, histologic changes of atherosclerosis are present in 21% of grafts and in 27% of patients. Only approximately 60% of saphenous vein grafts remain patent at repeat angiography between 10 and 12 years after bypass surgery; 45% of patent grafts show atherosclerotic changes at angiography and 43% of patients show evidence of atherosclerosis in one or more saphenous vein grafts. We do not know whether the development or the progression of these atherosclerotic changes can be modified; however, the data currently available suggest that the administration of platelet inhibitors and/or of lipid lowering agents offer two promising avenues of investigation in patients undergoing aortocoronary saphenous vein bypass surgery. Until this has been carefully studied, the internal mammary artery should remain the preferred conduit for aortocoronary bypass grafting, whenever possible.

Angiography↗
PubMed1985

Prognostic significance of progression of coronary artery disease.

Angiographically documented coronary artery disease (CAD) can progress. Although progression itself is frequently recognized in patients who have undergone repeat cardiac catheterization, its prognostic significance remains unclear. To evaluate the influence of progression on survival, 313 patients with CAD who underwent catheterization twice (39 +/- 25 months apart) were followed for 3 to 129 months (mean 41 +/- 30) after the second angiogram. At the time of the second angiogram, 21, 91, 113 and 88 patients had 0-, 1-, 2- and 3-vessel CAD, respectively. The mean ejection fraction (EF) of the group was 55 +/- 13%. Progression was noted in 139 patients (44%). Of the 313 patients, 33 died and 39 had acute myocardial infarction (AMI) during follow-up. Four-year survival was estimated at 94% and 83% in the nonprogression and progression groups, respectively. Progression was predictive of survival by (univariate) long-rank test (p less than 0.01), but only EF (p less than 0.001), number of diseased vessels (p less than 0.01) and percent stenosis in the left main coronary artery (p less than 0.05) were independently significant by (multivariate) Cox regression analysis. Four-year survival without AMI was 89% and 73% in the nonprogression and progression groups, respectively. Progression was related to survival without AMI (p less than 0.001) by log-rank test. Cox regression analysis provided 3 independent predictors of survival without AMI: number of diseased vessels (p less than 0.01), progression (p less than 0.01), relative risk = 2.28) and EF (p less than 0.01). Results were similar when analyzing only the 39 AMIs.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗
PubMed1985

Course of angina 1 to 12 years after aortocoronary bypass surgery related to changes in grafts and native coronary arteries.

Among 500 patients who received aortocoronary saphenous vein grafts at the Montreal heart Institute between September 1969 and August 1972, the condition in 88% of survivors with respect to angina pectoris was improved 1 year after surgery and 47% were still better after 12 years. One year after grafting, 202 patients underwent follow-up angiography; symptoms of angina had lessened in 89% who had at least one graft patent but in only 57.5% of those with all grafts occluded. This difference was still obvious 12 years after surgery. Loss of improvement decreased at a mean annual rate of 3.7%. Of the 59 angina-free patients at 1 year who had angiographic follow-up at 10 to 12 years, angina developed subsequently in 30 (51%); 25 (83%) of these were found to have obstructive changes that reduced the lumen by at least 50% in grafts or in ungrafted coronary arteries, compared with only 13 (45%) of the 29 angina-free patients who did not have angina subsequently. Improvement in the degree of angina and its recurrence after bypass surgery are closely related to graft patency and subsequent development of atherosclerosis in the grafts or in the native coronary arteries.

Adult↗
PubMed1985

Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences.

Both the Veterans Administration Cooperative Study and the European Coronary Surgery Study have provided only brief accounts of graft patency rates in their surgically treated patients. In the Veterans Administration Cooperative Study, at an average of 1 year after operation, 69% of the grafts were patent among 208 patients; 88% of patients had at least one patent graft, and 58% had all grafts patent. In the European Coronary Surgery Study, angiographic examination of the grafts was performed within 9 months of operation in 84 patients, and showed a patency rate of 90%; in 223 patients, the examination was performed at between 9 and 18 months, and showed a 77% patency rate. In the Coronary Artery Surgery Study (CASS), graft patency rates were evaluated within 60 days of operation in 129 patients, a median of 18 months after operation in 121 patients, and a median of 5 years after operation in 197 patients. Cumulative vein graft patency (per distal anastomosis) was 90% early, 82% at 18 months, and 82% at 5 years. At least one graft anastomosis was patent early in 97% of patients, at 18 months in 96% of patients, and at 5 years in 97% of patients; all graft anastomoses were patent early in 81% of patients, at 18 months in 70% of patients, and at 5 years in 67% of patients. The incidence of vein graft stenosis of 50% or more was 10% at 18 months and 8% at 5 years after operation. The excellent results reported in CASS were associated with marked improvement in quality of life and excellent survival 5 years after operation in surgically treated patients, as previously reported.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1979

Prophylactic coronary artery grafting in patients with few or no symptoms.

Fifty-five patients who underwent prophylactic coronary artery grafting were followed for 4 to 8 years. Sixteen patients had no angina, and 39 were in New York Heart Association Functional Class I. Twenty-one patients had single-vessel disease, 13 had double-vessel disease, and 27, triple-vessel disease. A total of 101 grafts were inserted. There were no operative deaths. Two patients suffered a perioperative myocardial infarction (MI), and 3 were reoperated on for persistent bleeding. Early after operation, 9 of the 45 grafts were occluded. At 1 year, 2 patients had occlusion of all grafts, and 1 had similar findings at 5 years. There were 4 late deaths, 3 related to coronary artery disease. Seven patients sustained a late MI. Thirty-one of the 51 survivors (60.8%) seen late (mean, 69.3 months) after operation were free from angina; 14 were in Class I and 6, Class II. It is apparent from this retrospective study that patients such as these stand to benefit little from prophylactic revascularization. Longevity may be increased, however, in patients who are asymptomatic after MI.

Adult↗
PubMed1979

Loss of the improvement of angina between 1 and 7 years after aortocoronary bypass surgery: correlations with changes in vein grafts and in coronary arteries.

Improvement of effort angina following pure aortocoronary bypass graft surgery was related to postoperative control angiographic studies of grafts and coronary arteries in 75 unselected patients. Clinical and angiographic evaluations were carried out at approximately 1 year and at 5 to 7 years after surgery. At 1 year, 61 (81.3%) were improved (52 without angina and 9 with partial improvement by at least two functional classes), whereas 14 were unimproved (18.7%). At approximately 6 years, loss of improvement (reappearance of angina or aggravation by at least two functional classes) was observed in 22 of the 61 improved patients, representing an attrition of 36.1% over a 5-year period. Graft occlusion or a narrowing of over 50% was observed in two of the 39 patients in whom improvement had continued (5.1%), whereas it was found in six of the 22 patients (27.3%) whose results deteriorated (p less than 0.05). Similarly, progression to occlusion of a preexisting stenosis of over 50% or appearance of a new stenosis of over 50% in a major coronary artery (distal to a graft or in an unbypassed artery) was observed in five of the 39 patients with continued improvement (12.8%) and in 11 of the 22 patients whose condition deteriorated (p less than 0.01). Changes in a graft or in a coronary artery were noted in 63.6% (14/22) of the patients with loss of improvement as compared to only 18% (7/39) of the patients whose improvement did not deteriorate. Improvement of angina was also evaluated in all survivors among our first 500 cases who had preoperative effort angina and pure bypass surgery with or without angiographic studies. Of these 260 patients, 70.4% were angina-free or improved by two to three functional classes at 1 year, and only 41.9% at 7 years after surgery. It is concluded that the effect of aortocoronary bypass graft surgery is transient in a high proportion of patients and that deterioration of results is related to late graft modifications and progression of atherosclerosis, particularly in ungrafted coronary arteries.

Adult↗